GXP ACADEMY · GXP INSIGHTS
Practical analysis of GMP, Pharmaceutical Quality Systems, deviations, CAPA, change control, audits and risk management. Built to support sound interpretation, defensible decisions and stronger evidence.
ANALYSIS & PRACTICAL GUIDES
Quality systems, audit readiness and GMP processes explained through concrete criteria, examples and practical points of attention.
How to write a GMP internal audit report with clear and defensible findings, classify Critical/Major/Minor, define robust CAPA and perform effectiveness checks. Includes ready-to-use templates and an “inspection...
Read the article →
Practical checklist to defend the VMP during inspection: typical questions, how to prepare the war room, errors that generate findings and how to manage gaps.
Read the article →
Practical guide to conducting a GMP internal audit: audit plan and checklist, opening meeting, effective questions, evidence collection, time management and closing meeting. With ready-to-use examples.
Read the article →
Risk-based method to decide when E&L studies are required. Matrix, examples, audit-defensible criteria and focus on inspection expectations.
Read the article →
How to build a risk-based annual GMP internal audit programme according to ICH Q9/Q10: audit universe, risk matrix, frequencies, independent auditors, KPIs and ready-to-use templates.
Read the article →
How to build an effective Environmental Monitoring Programme: particles, microbiology, ΔP, alert/action limits, trending, data integrity and response to deviations.
Read the article →
How to build a robust cleaning & sanitisation programme: surfaces, frequencies, disinfectants, residues, special cleaning and audit readiness.
Read the article →
How to perform an effective cleanroom Impact Assessment: technical factors, real examples, mitigations and integration with OCP/CCS.
Read the article →
Since 16 July 2026, Commission Implementing Regulations (EU) 2025/2091 and (EU) 2025/2154 have applied directly across EU Member States. Their technical content is closely aligned with EU GMP for human...
Since 16 July 2026, Commission Implementing Regulations (EU) 2025/2091 and (EU) 2025/2154 have applied directly across EU Member States. Their technical content is closely aligned with EU GMP for human...
PIC/S has published PI 006-4, a revised 49-page guidance document on qualification and validation which supersedes PI 006-3 and enters into force on 1 October 2026. GMP manufacturers should now...
PIC/S has published PI 006-4, a revised 49-page guidance document on qualification and validation which supersedes PI 006-3 and enters into force on 1 October 2026. GMP manufacturers should now...
PIC/S has published draft guidelines for a new Annex 22: Artificial Intelligence. The proposal sets out a lifecycle-oriented framework for static, deterministic AI/ML models used in critical GMP applications, with...
PIC/S has published draft guidelines for a new Annex 22: Artificial Intelligence. The proposal sets out a lifecycle-oriented framework for static, deterministic AI/ML models used in critical GMP applications, with...
EMA’s Annex 22 work places adaptive, probabilistic and generative AI at the centre of a GMP control-strategy discussion. The final guidance is not yet available; manufacturers can nevertheless prepare a...
EMA’s Annex 22 work places adaptive, probabilistic and generative AI at the centre of a GMP control-strategy discussion. The final guidance is not yet available; manufacturers can nevertheless prepare a...
The revised EU GMP Annex 19 becomes applicable on 24 September 2026. Its most material new provisions address reference and retention samples for parallel imported, parallel distributed and parallel traded...
The revised EU GMP Annex 19 becomes applicable on 24 September 2026. Its most material new provisions address reference and retention samples for parallel imported, parallel distributed and parallel traded...
EMA’s 2026–2027 pilot puts risk-based change management under practical inspection focus. For GMP leaders, the issue is no longer only whether the PQS is documented, but whether its operation can...
EMA’s 2026–2027 pilot puts risk-based change management under practical inspection focus. For GMP leaders, the issue is no longer only whether the PQS is documented, but whether its operation can...
PRACTICAL GMP TOOLS FOR PHARMA
GuideGxP turns complex GMP requirements into operational guides, editable templates and practical insights for pharmaceutical professionals.
Add GuideGxP to your preferred sources
Find our GMP content more easily on Google, in AI Overviews and AI Mode.
